Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | -1.38% | -3.85% | +36.36% |
20/05 | Nuo Therapeutics, Inc. announced that it has received $0.650875 million in funding | CI |
15/05 | Nuo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
+36.36% | 3.32Cr | |
+10.47% | 11TCr | |
+10.61% | 10TCr | |
-5.62% | 2.38TCr | |
-0.82% | 2.17TCr | |
-10.12% | 1.81TCr | |
-42.12% | 1.63TCr | |
-16.89% | 1.61TCr | |
+2.67% | 1.38TCr | |
+32.46% | 1.18TCr |
- Stock Market
- Equities
- AURX Stock
- News Nuo Therapeutics, Inc.
- Transcript : Cytomedix, Inc., Q1 2013 Earnings Call, May 10, 2013